TREY WILSON: Open Payments
NPI 1417602194 · HUNTSVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,911 in 139 payments from 14 companies in 2025. Trend: 2023 $1,593 · 2024 $2,487 · 2025 $2,911
Food & beverage: $2,911
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $792 |
| Madrigal Pharmaceuticals | 15 | $538 |
| Janssen Biotech, Inc. | 14 | $374 |
| Ardelyx, Inc. | 15 | $279 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 13 | $182 |
| GENZYME CORPORATION | 8 | $179 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $150 |
| Regeneron Healthcare Solutions, Inc. | 5 | $116 |
| Phathom Pharmaceuticals, Inc. | 15 | $113 |
| Lilly USA, LLC | 3 | $61 |
Products named: REZDIFFRA, TREMFYA, RINVOQ, SKYRIZI, DUPIXENT, IBSRELA, ENTYVIO, XIFAXAN.
Industry payments across AL — which companies pay providers there.
